nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR6—Cyproheptadine—allergic rhinitis	0.213	0.282	CbGbCtD
Methysergide—HTR2B—Cyproheptadine—allergic rhinitis	0.19	0.252	CbGbCtD
Methysergide—HTR2C—Cyproheptadine—allergic rhinitis	0.124	0.164	CbGbCtD
Methysergide—HTR1A—Cyproheptadine—allergic rhinitis	0.117	0.155	CbGbCtD
Methysergide—HTR2A—Cyproheptadine—allergic rhinitis	0.112	0.148	CbGbCtD
Methysergide—SIGMAR1—Levonorgestrel—Hydrocortisone—allergic rhinitis	0.0013	1	CbGdCrCtD
Methysergide—Insomnia—Loratadine—allergic rhinitis	0.000529	0.00259	CcSEcCtD
Methysergide—Tachycardia—Flunisolide—allergic rhinitis	0.000528	0.00259	CcSEcCtD
Methysergide—Paraesthesia—Loratadine—allergic rhinitis	0.000525	0.00258	CcSEcCtD
Methysergide—Somnolence—Loratadine—allergic rhinitis	0.00052	0.00255	CcSEcCtD
Methysergide—Diarrhoea—Dimenhydrinate—allergic rhinitis	0.00052	0.00255	CcSEcCtD
Methysergide—Diarrhoea—Diphenhydramine—allergic rhinitis	0.00052	0.00255	CcSEcCtD
Methysergide—Dyspepsia—Loratadine—allergic rhinitis	0.000515	0.00252	CcSEcCtD
Methysergide—Dizziness—Olopatadine—allergic rhinitis	0.000513	0.00252	CcSEcCtD
Methysergide—Euphoric mood—Dexamethasone—allergic rhinitis	0.000513	0.00251	CcSEcCtD
Methysergide—Euphoric mood—Betamethasone—allergic rhinitis	0.000513	0.00251	CcSEcCtD
Methysergide—Gastrointestinal disorder—Loratadine—allergic rhinitis	0.000505	0.00248	CcSEcCtD
Methysergide—Fatigue—Loratadine—allergic rhinitis	0.000505	0.00247	CcSEcCtD
Methysergide—Dizziness—Dimenhydrinate—allergic rhinitis	0.000502	0.00246	CcSEcCtD
Methysergide—Dizziness—Diphenhydramine—allergic rhinitis	0.000502	0.00246	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Cetirizine—allergic rhinitis	0.000502	0.00246	CcSEcCtD
Methysergide—Thrombophlebitis—Dexamethasone—allergic rhinitis	0.000501	0.00245	CcSEcCtD
Methysergide—Thrombophlebitis—Betamethasone—allergic rhinitis	0.000501	0.00245	CcSEcCtD
Methysergide—Constipation—Loratadine—allergic rhinitis	0.0005	0.00245	CcSEcCtD
Methysergide—Pain—Loratadine—allergic rhinitis	0.0005	0.00245	CcSEcCtD
Methysergide—Insomnia—Cetirizine—allergic rhinitis	0.000498	0.00244	CcSEcCtD
Methysergide—Paraesthesia—Cetirizine—allergic rhinitis	0.000494	0.00242	CcSEcCtD
Methysergide—Vomiting—Olopatadine—allergic rhinitis	0.000494	0.00242	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Flunisolide—allergic rhinitis	0.000493	0.00242	CcSEcCtD
Methysergide—Dyspnoea—Cetirizine—allergic rhinitis	0.000491	0.00241	CcSEcCtD
Methysergide—Convulsion—Montelukast—allergic rhinitis	0.00049	0.0024	CcSEcCtD
Methysergide—Insomnia—Flunisolide—allergic rhinitis	0.00049	0.0024	CcSEcCtD
Methysergide—Rash—Olopatadine—allergic rhinitis	0.00049	0.0024	CcSEcCtD
Methysergide—Somnolence—Cetirizine—allergic rhinitis	0.000489	0.0024	CcSEcCtD
Methysergide—Dermatitis—Olopatadine—allergic rhinitis	0.000489	0.0024	CcSEcCtD
Methysergide—Dyspepsia—Cetirizine—allergic rhinitis	0.000485	0.00238	CcSEcCtD
Methysergide—Vomiting—Dimenhydrinate—allergic rhinitis	0.000483	0.00237	CcSEcCtD
Methysergide—Vomiting—Diphenhydramine—allergic rhinitis	0.000483	0.00237	CcSEcCtD
Methysergide—Dyspnoea—Flunisolide—allergic rhinitis	0.000483	0.00237	CcSEcCtD
Methysergide—Feeling abnormal—Loratadine—allergic rhinitis	0.000482	0.00236	CcSEcCtD
Methysergide—Arthralgia—Montelukast—allergic rhinitis	0.000482	0.00236	CcSEcCtD
Methysergide—Myalgia—Montelukast—allergic rhinitis	0.000482	0.00236	CcSEcCtD
Methysergide—Rash—Diphenhydramine—allergic rhinitis	0.000479	0.00235	CcSEcCtD
Methysergide—Rash—Dimenhydrinate—allergic rhinitis	0.000479	0.00235	CcSEcCtD
Methysergide—Dermatitis—Diphenhydramine—allergic rhinitis	0.000479	0.00235	CcSEcCtD
Methysergide—Dermatitis—Dimenhydrinate—allergic rhinitis	0.000479	0.00235	CcSEcCtD
Methysergide—Gastrointestinal pain—Loratadine—allergic rhinitis	0.000479	0.00235	CcSEcCtD
Methysergide—Dyspepsia—Flunisolide—allergic rhinitis	0.000477	0.00234	CcSEcCtD
Methysergide—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.000475	0.00233	CcSEcCtD
Methysergide—Fatigue—Cetirizine—allergic rhinitis	0.000475	0.00233	CcSEcCtD
Methysergide—Pain—Cetirizine—allergic rhinitis	0.000471	0.00231	CcSEcCtD
Methysergide—Constipation—Cetirizine—allergic rhinitis	0.000471	0.00231	CcSEcCtD
Methysergide—Fatigue—Flunisolide—allergic rhinitis	0.000467	0.00229	CcSEcCtD
Methysergide—Constipation—Flunisolide—allergic rhinitis	0.000463	0.00227	CcSEcCtD
Methysergide—Pain—Flunisolide—allergic rhinitis	0.000463	0.00227	CcSEcCtD
Methysergide—Abdominal pain—Loratadine—allergic rhinitis	0.000463	0.00227	CcSEcCtD
Methysergide—Body temperature increased—Loratadine—allergic rhinitis	0.000463	0.00227	CcSEcCtD
Methysergide—Oedema—Montelukast—allergic rhinitis	0.000462	0.00226	CcSEcCtD
Methysergide—Nausea—Olopatadine—allergic rhinitis	0.000461	0.00226	CcSEcCtD
Methysergide—Feeling abnormal—Cetirizine—allergic rhinitis	0.000454	0.00222	CcSEcCtD
Methysergide—Thrombocytopenia—Montelukast—allergic rhinitis	0.000452	0.00222	CcSEcCtD
Methysergide—Nausea—Diphenhydramine—allergic rhinitis	0.000451	0.00221	CcSEcCtD
Methysergide—Nausea—Dimenhydrinate—allergic rhinitis	0.000451	0.00221	CcSEcCtD
Methysergide—Gastrointestinal pain—Cetirizine—allergic rhinitis	0.00045	0.00221	CcSEcCtD
Methysergide—Feeling abnormal—Flunisolide—allergic rhinitis	0.000446	0.00219	CcSEcCtD
Methysergide—Gastrointestinal pain—Flunisolide—allergic rhinitis	0.000443	0.00217	CcSEcCtD
Methysergide—Body temperature increased—Cetirizine—allergic rhinitis	0.000435	0.00213	CcSEcCtD
Methysergide—Abdominal pain—Cetirizine—allergic rhinitis	0.000435	0.00213	CcSEcCtD
Methysergide—Body temperature increased—Flunisolide—allergic rhinitis	0.000428	0.0021	CcSEcCtD
Methysergide—Abdominal pain—Flunisolide—allergic rhinitis	0.000428	0.0021	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Montelukast—allergic rhinitis	0.000421	0.00206	CcSEcCtD
Methysergide—Asthenia—Loratadine—allergic rhinitis	0.00042	0.00206	CcSEcCtD
Methysergide—Insomnia—Montelukast—allergic rhinitis	0.000418	0.00205	CcSEcCtD
Methysergide—Paraesthesia—Montelukast—allergic rhinitis	0.000415	0.00203	CcSEcCtD
Methysergide—Somnolence—Montelukast—allergic rhinitis	0.00041	0.00201	CcSEcCtD
Methysergide—Weight increased—Prednisolone—allergic rhinitis	0.000409	0.002	CcSEcCtD
Methysergide—Dyspepsia—Montelukast—allergic rhinitis	0.000406	0.00199	CcSEcCtD
Methysergide—Diarrhoea—Loratadine—allergic rhinitis	0.0004	0.00196	CcSEcCtD
Methysergide—Weight increased—Hydrocortisone—allergic rhinitis	0.000399	0.00196	CcSEcCtD
Methysergide—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000399	0.00195	CcSEcCtD
Methysergide—Fatigue—Montelukast—allergic rhinitis	0.000398	0.00195	CcSEcCtD
Methysergide—Weight decreased—Hydrocortisone—allergic rhinitis	0.000397	0.00194	CcSEcCtD
Methysergide—Asthenia—Cetirizine—allergic rhinitis	0.000395	0.00194	CcSEcCtD
Methysergide—Pain—Montelukast—allergic rhinitis	0.000395	0.00194	CcSEcCtD
Methysergide—Asthenia—Flunisolide—allergic rhinitis	0.000388	0.0019	CcSEcCtD
Methysergide—Dizziness—Loratadine—allergic rhinitis	0.000387	0.0019	CcSEcCtD
Methysergide—Gastrointestinal pain—Montelukast—allergic rhinitis	0.000378	0.00185	CcSEcCtD
Methysergide—Diarrhoea—Cetirizine—allergic rhinitis	0.000377	0.00185	CcSEcCtD
Methysergide—Weight increased—Triamcinolone—allergic rhinitis	0.000376	0.00184	CcSEcCtD
Methysergide—Weight increased—Methylprednisolone—allergic rhinitis	0.000375	0.00184	CcSEcCtD
Methysergide—Vomiting—Loratadine—allergic rhinitis	0.000372	0.00182	CcSEcCtD
Methysergide—Diarrhoea—Flunisolide—allergic rhinitis	0.00037	0.00182	CcSEcCtD
Methysergide—Rash—Loratadine—allergic rhinitis	0.000369	0.00181	CcSEcCtD
Methysergide—Dermatitis—Loratadine—allergic rhinitis	0.000369	0.00181	CcSEcCtD
Methysergide—Body temperature increased—Montelukast—allergic rhinitis	0.000365	0.00179	CcSEcCtD
Methysergide—Abdominal pain—Montelukast—allergic rhinitis	0.000365	0.00179	CcSEcCtD
Methysergide—Dizziness—Cetirizine—allergic rhinitis	0.000364	0.00178	CcSEcCtD
Methysergide—Dizziness—Flunisolide—allergic rhinitis	0.000358	0.00175	CcSEcCtD
Methysergide—Vomiting—Cetirizine—allergic rhinitis	0.00035	0.00172	CcSEcCtD
Methysergide—Nausea—Loratadine—allergic rhinitis	0.000348	0.0017	CcSEcCtD
Methysergide—Rash—Cetirizine—allergic rhinitis	0.000347	0.0017	CcSEcCtD
Methysergide—Dermatitis—Cetirizine—allergic rhinitis	0.000347	0.0017	CcSEcCtD
Methysergide—Vomiting—Flunisolide—allergic rhinitis	0.000344	0.00169	CcSEcCtD
Methysergide—Rash—Flunisolide—allergic rhinitis	0.000341	0.00167	CcSEcCtD
Methysergide—Dermatitis—Flunisolide—allergic rhinitis	0.000341	0.00167	CcSEcCtD
Methysergide—Weight increased—Betamethasone—allergic rhinitis	0.000341	0.00167	CcSEcCtD
Methysergide—Weight increased—Dexamethasone—allergic rhinitis	0.000341	0.00167	CcSEcCtD
Methysergide—Weight decreased—Betamethasone—allergic rhinitis	0.000339	0.00166	CcSEcCtD
Methysergide—Weight decreased—Dexamethasone—allergic rhinitis	0.000339	0.00166	CcSEcCtD
Methysergide—Asthenia—Montelukast—allergic rhinitis	0.000331	0.00162	CcSEcCtD
Methysergide—Nausea—Cetirizine—allergic rhinitis	0.000327	0.0016	CcSEcCtD
Methysergide—Nausea—Flunisolide—allergic rhinitis	0.000322	0.00158	CcSEcCtD
Methysergide—Diarrhoea—Montelukast—allergic rhinitis	0.000316	0.00155	CcSEcCtD
Methysergide—Dizziness—Montelukast—allergic rhinitis	0.000305	0.0015	CcSEcCtD
Methysergide—Vomiting—Montelukast—allergic rhinitis	0.000294	0.00144	CcSEcCtD
Methysergide—Rash—Montelukast—allergic rhinitis	0.000291	0.00143	CcSEcCtD
Methysergide—Dermatitis—Montelukast—allergic rhinitis	0.000291	0.00143	CcSEcCtD
Methysergide—Ill-defined disorder—Prednisolone—allergic rhinitis	0.00029	0.00142	CcSEcCtD
Methysergide—Ill-defined disorder—Hydrocortisone—allergic rhinitis	0.000283	0.00139	CcSEcCtD
Methysergide—Malaise—Prednisolone—allergic rhinitis	0.000282	0.00138	CcSEcCtD
Methysergide—Back pain—Triamcinolone—allergic rhinitis	0.000278	0.00136	CcSEcCtD
Methysergide—Malaise—Hydrocortisone—allergic rhinitis	0.000276	0.00135	CcSEcCtD
Methysergide—Nausea—Montelukast—allergic rhinitis	0.000274	0.00134	CcSEcCtD
Methysergide—Convulsion—Prednisolone—allergic rhinitis	0.000271	0.00133	CcSEcCtD
Methysergide—Ill-defined disorder—Triamcinolone—allergic rhinitis	0.000267	0.00131	CcSEcCtD
Methysergide—Ill-defined disorder—Methylprednisolone—allergic rhinitis	0.000266	0.00131	CcSEcCtD
Methysergide—Alopecia—Dexamethasone—allergic rhinitis	0.000265	0.0013	CcSEcCtD
Methysergide—Alopecia—Betamethasone—allergic rhinitis	0.000265	0.0013	CcSEcCtD
Methysergide—Convulsion—Hydrocortisone—allergic rhinitis	0.000265	0.0013	CcSEcCtD
Methysergide—Discomfort—Prednisolone—allergic rhinitis	0.000263	0.00129	CcSEcCtD
Methysergide—Myalgia—Hydrocortisone—allergic rhinitis	0.00026	0.00127	CcSEcCtD
Methysergide—Malaise—Triamcinolone—allergic rhinitis	0.000259	0.00127	CcSEcCtD
Methysergide—Malaise—Methylprednisolone—allergic rhinitis	0.000259	0.00127	CcSEcCtD
Methysergide—Discomfort—Hydrocortisone—allergic rhinitis	0.000257	0.00126	CcSEcCtD
Methysergide—Oedema—Prednisolone—allergic rhinitis	0.000255	0.00125	CcSEcCtD
Methysergide—Oedema—Hydrocortisone—allergic rhinitis	0.000249	0.00122	CcSEcCtD
Methysergide—Convulsion—Triamcinolone—allergic rhinitis	0.000249	0.00122	CcSEcCtD
Methysergide—Tachycardia—Prednisolone—allergic rhinitis	0.000249	0.00122	CcSEcCtD
Methysergide—Convulsion—Methylprednisolone—allergic rhinitis	0.000249	0.00122	CcSEcCtD
Methysergide—Myalgia—Triamcinolone—allergic rhinitis	0.000245	0.0012	CcSEcCtD
Methysergide—Arthralgia—Methylprednisolone—allergic rhinitis	0.000244	0.0012	CcSEcCtD
Methysergide—Myalgia—Methylprednisolone—allergic rhinitis	0.000244	0.0012	CcSEcCtD
Methysergide—Tachycardia—Hydrocortisone—allergic rhinitis	0.000243	0.00119	CcSEcCtD
Methysergide—Ill-defined disorder—Betamethasone—allergic rhinitis	0.000242	0.00119	CcSEcCtD
Methysergide—Ill-defined disorder—Dexamethasone—allergic rhinitis	0.000242	0.00119	CcSEcCtD
Methysergide—Discomfort—Triamcinolone—allergic rhinitis	0.000242	0.00119	CcSEcCtD
Methysergide—Discomfort—Methylprednisolone—allergic rhinitis	0.000241	0.00118	CcSEcCtD
Methysergide—Malaise—Dexamethasone—allergic rhinitis	0.000235	0.00115	CcSEcCtD
Methysergide—Malaise—Betamethasone—allergic rhinitis	0.000235	0.00115	CcSEcCtD
Methysergide—Oedema—Triamcinolone—allergic rhinitis	0.000235	0.00115	CcSEcCtD
Methysergide—HTR1D—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000232	0.00588	CbGpPWpGaD
Methysergide—Insomnia—Prednisolone—allergic rhinitis	0.000231	0.00113	CcSEcCtD
Methysergide—HTR1A—SIDS Susceptibility Pathways—IL13—allergic rhinitis	0.00023	0.00584	CbGpPWpGaD
Methysergide—Paraesthesia—Prednisolone—allergic rhinitis	0.000229	0.00112	CcSEcCtD
Methysergide—Tachycardia—Triamcinolone—allergic rhinitis	0.000229	0.00112	CcSEcCtD
Methysergide—Tachycardia—Methylprednisolone—allergic rhinitis	0.000229	0.00112	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	0.000227	0.00111	CcSEcCtD
Methysergide—HTR1B—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000227	0.00576	CbGpPWpGaD
Methysergide—HTR6—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000227	0.00575	CbGpPWpGaD
Methysergide—HTR7—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000226	0.00574	CbGpPWpGaD
Methysergide—Convulsion—Betamethasone—allergic rhinitis	0.000226	0.00111	CcSEcCtD
Methysergide—Convulsion—Dexamethasone—allergic rhinitis	0.000226	0.00111	CcSEcCtD
Methysergide—HTR2B—G alpha (q) signalling events—TAC1—allergic rhinitis	0.000226	0.00573	CbGpPWpGaD
Methysergide—HTR6—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000226	0.00572	CbGpPWpGaD
Methysergide—Insomnia—Hydrocortisone—allergic rhinitis	0.000226	0.00111	CcSEcCtD
Methysergide—HTR2A—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	0.000225	0.00572	CbGpPWpGaD
Methysergide—HTR7—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000225	0.00572	CbGpPWpGaD
Methysergide—HTR1D—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000225	0.00571	CbGpPWpGaD
Methysergide—Paraesthesia—Hydrocortisone—allergic rhinitis	0.000224	0.0011	CcSEcCtD
Methysergide—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000224	0.00568	CbGpPWpGaD
Methysergide—Myalgia—Betamethasone—allergic rhinitis	0.000222	0.00109	CcSEcCtD
Methysergide—Myalgia—Dexamethasone—allergic rhinitis	0.000222	0.00109	CcSEcCtD
Methysergide—HTR2A—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.000222	0.00564	CbGpPWpGaD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00022	0.00559	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00022	0.00559	CbGpPWpGaD
Methysergide—Discomfort—Betamethasone—allergic rhinitis	0.00022	0.00108	CcSEcCtD
Methysergide—Discomfort—Dexamethasone—allergic rhinitis	0.00022	0.00108	CcSEcCtD
Methysergide—Dyspepsia—Hydrocortisone—allergic rhinitis	0.000219	0.00108	CcSEcCtD
Methysergide—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000219	0.00556	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000219	0.00556	CbGpPWpGaD
Methysergide—Pain—Prednisolone—allergic rhinitis	0.000218	0.00107	CcSEcCtD
Methysergide—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000215	0.00106	CcSEcCtD
Methysergide—Fatigue—Hydrocortisone—allergic rhinitis	0.000215	0.00105	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	0.000214	0.00105	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	0.000213	0.00105	CcSEcCtD
Methysergide—Pain—Hydrocortisone—allergic rhinitis	0.000213	0.00105	CcSEcCtD
Methysergide—HTR2B—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000213	0.00541	CbGpPWpGaD
Methysergide—Oedema—Dexamethasone—allergic rhinitis	0.000213	0.00104	CcSEcCtD
Methysergide—Oedema—Betamethasone—allergic rhinitis	0.000213	0.00104	CcSEcCtD
Methysergide—Insomnia—Triamcinolone—allergic rhinitis	0.000212	0.00104	CcSEcCtD
Methysergide—Insomnia—Methylprednisolone—allergic rhinitis	0.000212	0.00104	CcSEcCtD
Methysergide—HTR1A—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	0.000212	0.00537	CbGpPWpGaD
Methysergide—Paraesthesia—Triamcinolone—allergic rhinitis	0.000211	0.00103	CcSEcCtD
Methysergide—Feeling abnormal—Prednisolone—allergic rhinitis	0.00021	0.00103	CcSEcCtD
Methysergide—Paraesthesia—Methylprednisolone—allergic rhinitis	0.00021	0.00103	CcSEcCtD
Methysergide—HTR7—Circadian rythm related genes—ADIPOQ—allergic rhinitis	0.00021	0.00533	CbGpPWpGaD
Methysergide—Dyspnoea—Triamcinolone—allergic rhinitis	0.000209	0.00103	CcSEcCtD
Methysergide—Thrombocytopenia—Dexamethasone—allergic rhinitis	0.000209	0.00102	CcSEcCtD
Methysergide—Thrombocytopenia—Betamethasone—allergic rhinitis	0.000209	0.00102	CcSEcCtD
Methysergide—Tachycardia—Betamethasone—allergic rhinitis	0.000208	0.00102	CcSEcCtD
Methysergide—Tachycardia—Dexamethasone—allergic rhinitis	0.000208	0.00102	CcSEcCtD
Methysergide—HTR2B—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000207	0.00525	CbGpPWpGaD
Methysergide—Dyspepsia—Triamcinolone—allergic rhinitis	0.000207	0.00101	CcSEcCtD
Methysergide—Dyspepsia—Methylprednisolone—allergic rhinitis	0.000206	0.00101	CcSEcCtD
Methysergide—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000206	0.00522	CbGpPWpGaD
Methysergide—Feeling abnormal—Hydrocortisone—allergic rhinitis	0.000205	0.00101	CcSEcCtD
Methysergide—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	0.000204	0.000999	CcSEcCtD
Methysergide—Fatigue—Triamcinolone—allergic rhinitis	0.000202	0.000992	CcSEcCtD
Methysergide—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000202	0.00513	CbGpPWpGaD
Methysergide—Fatigue—Methylprednisolone—allergic rhinitis	0.000202	0.00099	CcSEcCtD
Methysergide—HTR1A—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.000202	0.00512	CbGpPWpGaD
Methysergide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.000202	0.00512	CbGpPWpGaD
Methysergide—Pain—Triamcinolone—allergic rhinitis	0.000201	0.000984	CcSEcCtD
Methysergide—HTR2C—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.000201	0.00509	CbGpPWpGaD
Methysergide—HTR2A—SIDS Susceptibility Pathways—IL13—allergic rhinitis	0.000199	0.00504	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000199	0.00504	CbGpPWpGaD
Methysergide—Abdominal pain—Hydrocortisone—allergic rhinitis	0.000197	0.000966	CcSEcCtD
Methysergide—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000197	0.000966	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	0.000194	0.000951	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	0.000194	0.000951	CcSEcCtD
Methysergide—HTR1F—GPCR ligand binding—TAC1—allergic rhinitis	0.000194	0.00491	CbGpPWpGaD
Methysergide—Feeling abnormal—Triamcinolone—allergic rhinitis	0.000193	0.000948	CcSEcCtD
Methysergide—Feeling abnormal—Methylprednisolone—allergic rhinitis	0.000193	0.000946	CcSEcCtD
Methysergide—Insomnia—Betamethasone—allergic rhinitis	0.000193	0.000944	CcSEcCtD
Methysergide—Insomnia—Dexamethasone—allergic rhinitis	0.000193	0.000944	CcSEcCtD
Methysergide—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	0.000192	0.000939	CcSEcCtD
Methysergide—Paraesthesia—Dexamethasone—allergic rhinitis	0.000191	0.000938	CcSEcCtD
Methysergide—Paraesthesia—Betamethasone—allergic rhinitis	0.000191	0.000938	CcSEcCtD
Methysergide—HTR2A—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00019	0.00483	CbGpPWpGaD
Methysergide—Dyspepsia—Betamethasone—allergic rhinitis	0.000188	0.000919	CcSEcCtD
Methysergide—Dyspepsia—Dexamethasone—allergic rhinitis	0.000188	0.000919	CcSEcCtD
Methysergide—HTR1E—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000187	0.00476	CbGpPWpGaD
Methysergide—Body temperature increased—Triamcinolone—allergic rhinitis	0.000186	0.00091	CcSEcCtD
Methysergide—Abdominal pain—Methylprednisolone—allergic rhinitis	0.000185	0.000908	CcSEcCtD
Methysergide—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000184	0.000901	CcSEcCtD
Methysergide—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000184	0.000901	CcSEcCtD
Methysergide—Fatigue—Betamethasone—allergic rhinitis	0.000184	0.0009	CcSEcCtD
Methysergide—Fatigue—Dexamethasone—allergic rhinitis	0.000184	0.0009	CcSEcCtD
Methysergide—HTR2A—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	0.000183	0.00464	CbGpPWpGaD
Methysergide—HTR1E—GPCR ligand binding—TAC1—allergic rhinitis	0.000183	0.00464	CbGpPWpGaD
Methysergide—HTR2C—G alpha (q) signalling events—TAC1—allergic rhinitis	0.000182	0.00462	CbGpPWpGaD
Methysergide—Pain—Betamethasone—allergic rhinitis	0.000182	0.000893	CcSEcCtD
Methysergide—Pain—Dexamethasone—allergic rhinitis	0.000182	0.000893	CcSEcCtD
Methysergide—HTR1F—Signaling by GPCR—PTGDR2—allergic rhinitis	0.00018	0.00458	CbGpPWpGaD
Methysergide—Asthenia—Hydrocortisone—allergic rhinitis	0.000179	0.000877	CcSEcCtD
Methysergide—HTR6—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000178	0.00451	CbGpPWpGaD
Methysergide—HTR7—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000178	0.00451	CbGpPWpGaD
Methysergide—HTR1D—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000176	0.00448	CbGpPWpGaD
Methysergide—Feeling abnormal—Dexamethasone—allergic rhinitis	0.000176	0.00086	CcSEcCtD
Methysergide—Feeling abnormal—Betamethasone—allergic rhinitis	0.000176	0.00086	CcSEcCtD
Methysergide—HTR2A—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.000174	0.00442	CbGpPWpGaD
Methysergide—Gastrointestinal pain—Dexamethasone—allergic rhinitis	0.000174	0.000854	CcSEcCtD
Methysergide—Gastrointestinal pain—Betamethasone—allergic rhinitis	0.000174	0.000854	CcSEcCtD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000173	0.00439	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000173	0.00438	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000172	0.00436	CbGpPWpGaD
Methysergide—HTR6—GPCR ligand binding—CCL11—allergic rhinitis	0.000172	0.00436	CbGpPWpGaD
Methysergide—HTR7—GPCR ligand binding—CCL11—allergic rhinitis	0.000172	0.00435	CbGpPWpGaD
Methysergide—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000171	0.000836	CcSEcCtD
Methysergide—HTR1D—GPCR ligand binding—CCL11—allergic rhinitis	0.00017	0.00432	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—PTGDR2—allergic rhinitis	0.00017	0.00432	CbGpPWpGaD
Methysergide—Dizziness—Prednisolone—allergic rhinitis	0.000169	0.000827	CcSEcCtD
Methysergide—Asthenia—Triamcinolone—allergic rhinitis	0.000168	0.000826	CcSEcCtD
Methysergide—Abdominal pain—Dexamethasone—allergic rhinitis	0.000168	0.000825	CcSEcCtD
Methysergide—Abdominal pain—Betamethasone—allergic rhinitis	0.000168	0.000825	CcSEcCtD
Methysergide—Body temperature increased—Dexamethasone—allergic rhinitis	0.000168	0.000825	CcSEcCtD
Methysergide—Body temperature increased—Betamethasone—allergic rhinitis	0.000168	0.000825	CcSEcCtD
Methysergide—Asthenia—Methylprednisolone—allergic rhinitis	0.000168	0.000824	CcSEcCtD
Methysergide—HTR1A—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000168	0.00426	CbGpPWpGaD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000167	0.00424	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—CCL11—allergic rhinitis	0.000167	0.00423	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000167	0.00423	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000166	0.00421	CbGpPWpGaD
Methysergide—Dizziness—Hydrocortisone—allergic rhinitis	0.000165	0.000808	CcSEcCtD
Methysergide—HTR6—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000164	0.00416	CbGpPWpGaD
Methysergide—HTR7—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000164	0.00415	CbGpPWpGaD
Methysergide—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000163	0.00414	CbGpPWpGaD
Methysergide—HTR1D—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000163	0.00413	CbGpPWpGaD
Methysergide—HTR2B—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000162	0.00412	CbGpPWpGaD
Methysergide—Rash—Prednisolone—allergic rhinitis	0.000161	0.000789	CcSEcCtD
Methysergide—Dermatitis—Prednisolone—allergic rhinitis	0.000161	0.000788	CcSEcCtD
Methysergide—Diarrhoea—Methylprednisolone—allergic rhinitis	0.00016	0.000786	CcSEcCtD
Methysergide—HTR1B—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000159	0.00404	CbGpPWpGaD
Methysergide—Vomiting—Hydrocortisone—allergic rhinitis	0.000159	0.000777	CcSEcCtD
Methysergide—HTR2A—G alpha (q) signalling events—TAC1—allergic rhinitis	0.000158	0.00402	CbGpPWpGaD
Methysergide—Rash—Hydrocortisone—allergic rhinitis	0.000157	0.000771	CcSEcCtD
Methysergide—Dermatitis—Hydrocortisone—allergic rhinitis	0.000157	0.00077	CcSEcCtD
Methysergide—HTR2B—GPCR ligand binding—CCL11—allergic rhinitis	0.000157	0.00398	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000156	0.00396	CbGpPWpGaD
Methysergide—Dizziness—Triamcinolone—allergic rhinitis	0.000155	0.000761	CcSEcCtD
Methysergide—Dizziness—Methylprednisolone—allergic rhinitis	0.000155	0.000759	CcSEcCtD
Methysergide—Asthenia—Betamethasone—allergic rhinitis	0.000153	0.000749	CcSEcCtD
Methysergide—Asthenia—Dexamethasone—allergic rhinitis	0.000153	0.000749	CcSEcCtD
Methysergide—Nausea—Prednisolone—allergic rhinitis	0.000152	0.000743	CcSEcCtD
Methysergide—HTR2B—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.00015	0.0038	CbGpPWpGaD
Methysergide—HTR2A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000149	0.00379	CbGpPWpGaD
Methysergide—Vomiting—Triamcinolone—allergic rhinitis	0.000149	0.000732	CcSEcCtD
Methysergide—Vomiting—Methylprednisolone—allergic rhinitis	0.000149	0.00073	CcSEcCtD
Methysergide—Nausea—Hydrocortisone—allergic rhinitis	0.000148	0.000726	CcSEcCtD
Methysergide—Rash—Triamcinolone—allergic rhinitis	0.000148	0.000726	CcSEcCtD
Methysergide—Dermatitis—Triamcinolone—allergic rhinitis	0.000148	0.000725	CcSEcCtD
Methysergide—Rash—Methylprednisolone—allergic rhinitis	0.000148	0.000724	CcSEcCtD
Methysergide—Dermatitis—Methylprednisolone—allergic rhinitis	0.000148	0.000723	CcSEcCtD
Methysergide—HTR1E—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000147	0.00373	CbGpPWpGaD
Methysergide—Diarrhoea—Betamethasone—allergic rhinitis	0.000146	0.000714	CcSEcCtD
Methysergide—Diarrhoea—Dexamethasone—allergic rhinitis	0.000146	0.000714	CcSEcCtD
Methysergide—HTR2A—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000145	0.00368	CbGpPWpGaD
Methysergide—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000144	0.00366	CbGpPWpGaD
Methysergide—HTR1A—SIDS Susceptibility Pathways—IL10—allergic rhinitis	0.000144	0.00365	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000142	0.00359	CbGpPWpGaD
Methysergide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000142	0.00359	CbGpPWpGaD
Methysergide—Dizziness—Dexamethasone—allergic rhinitis	0.000141	0.00069	CcSEcCtD
Methysergide—Dizziness—Betamethasone—allergic rhinitis	0.000141	0.00069	CcSEcCtD
Methysergide—Nausea—Triamcinolone—allergic rhinitis	0.000139	0.000684	CcSEcCtD
Methysergide—Nausea—Methylprednisolone—allergic rhinitis	0.000139	0.000682	CcSEcCtD
Methysergide—HTR1F—Signaling by GPCR—CCL11—allergic rhinitis	0.000137	0.00347	CbGpPWpGaD
Methysergide—Vomiting—Dexamethasone—allergic rhinitis	0.000135	0.000664	CcSEcCtD
Methysergide—Vomiting—Betamethasone—allergic rhinitis	0.000135	0.000664	CcSEcCtD
Methysergide—Rash—Dexamethasone—allergic rhinitis	0.000134	0.000658	CcSEcCtD
Methysergide—Rash—Betamethasone—allergic rhinitis	0.000134	0.000658	CcSEcCtD
Methysergide—Dermatitis—Dexamethasone—allergic rhinitis	0.000134	0.000658	CcSEcCtD
Methysergide—Dermatitis—Betamethasone—allergic rhinitis	0.000134	0.000658	CcSEcCtD
Methysergide—HTR1E—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000134	0.00339	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000132	0.00334	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000131	0.00332	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—CCL11—allergic rhinitis	0.000129	0.00327	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000128	0.00325	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000128	0.00325	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—CCL11—allergic rhinitis	0.000127	0.00323	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000127	0.00323	CbGpPWpGaD
Methysergide—Nausea—Dexamethasone—allergic rhinitis	0.000127	0.00062	CcSEcCtD
Methysergide—Nausea—Betamethasone—allergic rhinitis	0.000127	0.00062	CcSEcCtD
Methysergide—HTR2C—GPCR ligand binding—CCL11—allergic rhinitis	0.000126	0.00321	CbGpPWpGaD
Methysergide—HTR6—GPCR ligand binding—TAC1—allergic rhinitis	0.000125	0.00317	CbGpPWpGaD
Methysergide—HTR7—GPCR ligand binding—TAC1—allergic rhinitis	0.000125	0.00316	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000124	0.00316	CbGpPWpGaD
Methysergide—HTR2A—SIDS Susceptibility Pathways—IL10—allergic rhinitis	0.000124	0.00316	CbGpPWpGaD
Methysergide—HTR1D—GPCR ligand binding—TAC1—allergic rhinitis	0.000124	0.00314	CbGpPWpGaD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000121	0.00308	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—TAC1—allergic rhinitis	0.000121	0.00308	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000121	0.00306	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000117	0.00297	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000116	0.00295	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000116	0.00295	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000115	0.00293	CbGpPWpGaD
Methysergide—HTR2B—GPCR ligand binding—TAC1—allergic rhinitis	0.000114	0.00289	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000114	0.00289	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000113	0.00287	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—CCL11—allergic rhinitis	0.00011	0.00279	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—TAC1—allergic rhinitis	0.000109	0.00278	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—PTGDR2—allergic rhinitis	0.000107	0.00271	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000106	0.00269	CbGpPWpGaD
Methysergide—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000105	0.00266	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—TAC1—allergic rhinitis	0.000103	0.00262	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—IL5—allergic rhinitis	0.000102	0.00258	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—PTGDR2—allergic rhinitis	0.000101	0.00255	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.0001	0.00255	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.0001	0.00255	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—CYSLTR1—allergic rhinitis	9.97e-05	0.00253	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—TAC1—allergic rhinitis	9.94e-05	0.00252	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	9.76e-05	0.00248	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—IL5—allergic rhinitis	9.6e-05	0.00244	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—PTGDR2—allergic rhinitis	9.48e-05	0.00241	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—PTGDR2—allergic rhinitis	9.43e-05	0.00239	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—TAC1—allergic rhinitis	9.37e-05	0.00238	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—IL5—allergic rhinitis	9.24e-05	0.00234	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—TAC1—allergic rhinitis	9.24e-05	0.00234	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—TAC1—allergic rhinitis	9.19e-05	0.00233	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	9.17e-05	0.00233	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—CYSLTR1—allergic rhinitis	9.13e-05	0.00232	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—CYSLTR1—allergic rhinitis	9.12e-05	0.00231	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—CYSLTR1—allergic rhinitis	9.06e-05	0.0023	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—CYSLTR1—allergic rhinitis	8.87e-05	0.00225	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—CCL11—allergic rhinitis	8.81e-05	0.00224	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—CCL11—allergic rhinitis	8.8e-05	0.00223	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—CCL11—allergic rhinitis	8.75e-05	0.00222	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—IL5—allergic rhinitis	8.71e-05	0.00221	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—PTGDR2—allergic rhinitis	8.61e-05	0.00218	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—CCL11—allergic rhinitis	8.56e-05	0.00217	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—PTGDR2—allergic rhinitis	8.56e-05	0.00217	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CYSLTR1—allergic rhinitis	8.37e-05	0.00212	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—CYSLTR1—allergic rhinitis	8.33e-05	0.00211	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—PTGDR2—allergic rhinitis	8.19e-05	0.00208	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CCL11—allergic rhinitis	8.08e-05	0.00205	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—CCL11—allergic rhinitis	8.04e-05	0.00204	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—TAC1—allergic rhinitis	7.98e-05	0.00202	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CYSLTR1—allergic rhinitis	7.89e-05	0.002	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CCL11—allergic rhinitis	7.62e-05	0.00193	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	7.44e-05	0.00189	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—PTGDR2—allergic rhinitis	7.44e-05	0.00189	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—CYSLTR1—allergic rhinitis	7.4e-05	0.00188	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—TAC1—allergic rhinitis	7.05e-05	0.00179	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—TAC1—allergic rhinitis	7.04e-05	0.00179	CbGpPWpGaD
Methysergide—HTR1A—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	7.04e-05	0.00179	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—TAC1—allergic rhinitis	7e-05	0.00178	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PTGDR2—allergic rhinitis	6.87e-05	0.00174	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PTGDR2—allergic rhinitis	6.86e-05	0.00174	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—TAC1—allergic rhinitis	6.85e-05	0.00174	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PTGDR2—allergic rhinitis	6.82e-05	0.00173	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—CYSLTR1—allergic rhinitis	6.75e-05	0.00171	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—CYSLTR1—allergic rhinitis	6.72e-05	0.00171	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PTGDR2—allergic rhinitis	6.68e-05	0.00169	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—IL5—allergic rhinitis	6.56e-05	0.00166	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—IL5—allergic rhinitis	6.55e-05	0.00166	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—CCL11—allergic rhinitis	6.52e-05	0.00166	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—IL5—allergic rhinitis	6.51e-05	0.00165	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—CCL11—allergic rhinitis	6.49e-05	0.00165	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—TAC1—allergic rhinitis	6.44e-05	0.00163	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	6.43e-05	0.00163	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—TAC1—allergic rhinitis	6.4e-05	0.00163	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—TAC1—allergic rhinitis	6.4e-05	0.00162	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—IL5—allergic rhinitis	6.37e-05	0.00162	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—TAC1—allergic rhinitis	6.35e-05	0.00161	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PTGDR2—allergic rhinitis	6.27e-05	0.00159	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—TAC1—allergic rhinitis	6.22e-05	0.00158	CbGpPWpGaD
Methysergide—HTR2A—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	6.08e-05	0.00154	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—IL5—allergic rhinitis	5.98e-05	0.00152	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—IL5—allergic rhinitis	5.95e-05	0.00151	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—IL5—allergic rhinitis	5.95e-05	0.00151	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—IL5—allergic rhinitis	5.91e-05	0.0015	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TAC1—allergic rhinitis	5.87e-05	0.00149	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—TAC1—allergic rhinitis	5.85e-05	0.00148	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.84e-05	0.00148	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—IL5—allergic rhinitis	5.78e-05	0.00147	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CCL11—allergic rhinitis	5.64e-05	0.00143	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TAC1—allergic rhinitis	5.54e-05	0.00141	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IL5—allergic rhinitis	5.46e-05	0.00138	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—IL5—allergic rhinitis	5.43e-05	0.00138	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CYSLTR1—allergic rhinitis	5.39e-05	0.00137	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CYSLTR1—allergic rhinitis	5.38e-05	0.00137	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CYSLTR1—allergic rhinitis	5.35e-05	0.00136	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CYSLTR1—allergic rhinitis	5.24e-05	0.00133	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—TAC1—allergic rhinitis	5.22e-05	0.00132	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CCL11—allergic rhinitis	5.21e-05	0.00132	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CCL11—allergic rhinitis	5.2e-05	0.00132	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—TAC1—allergic rhinitis	5.19e-05	0.00132	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CCL11—allergic rhinitis	5.17e-05	0.00131	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IL5—allergic rhinitis	5.15e-05	0.00131	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PTGDR2—allergic rhinitis	5.09e-05	0.00129	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CCL11—allergic rhinitis	5.06e-05	0.00128	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PTGDR2—allergic rhinitis	5.06e-05	0.00128	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CYSLTR1—allergic rhinitis	4.92e-05	0.00125	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—IL5—allergic rhinitis	4.85e-05	0.00123	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—IL5—allergic rhinitis	4.83e-05	0.00123	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CCL11—allergic rhinitis	4.75e-05	0.00121	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—TAC1—allergic rhinitis	4.74e-05	0.0012	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—TAC1—allergic rhinitis	4.72e-05	0.0012	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—TAC1—allergic rhinitis	4.51e-05	0.00114	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL5—allergic rhinitis	4.41e-05	0.00112	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PTGDR2—allergic rhinitis	4.39e-05	0.00111	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL5—allergic rhinitis	4.38e-05	0.00111	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—IL5—allergic rhinitis	4.19e-05	0.00106	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—TAC1—allergic rhinitis	4.09e-05	0.00104	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CYSLTR1—allergic rhinitis	3.99e-05	0.00101	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CYSLTR1—allergic rhinitis	3.97e-05	0.00101	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCL11—allergic rhinitis	3.85e-05	0.000978	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—SMAD3—allergic rhinitis	3.84e-05	0.000975	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCL11—allergic rhinitis	3.83e-05	0.000973	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL5—allergic rhinitis	3.81e-05	0.000966	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TAC1—allergic rhinitis	3.78e-05	0.00096	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TAC1—allergic rhinitis	3.78e-05	0.000959	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TAC1—allergic rhinitis	3.75e-05	0.000953	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TAC1—allergic rhinitis	3.68e-05	0.000933	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—SMAD3—allergic rhinitis	3.62e-05	0.000919	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL5—allergic rhinitis	3.52e-05	0.000892	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL5—allergic rhinitis	3.51e-05	0.000891	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL5—allergic rhinitis	3.49e-05	0.000886	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TAC1—allergic rhinitis	3.45e-05	0.000876	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CYSLTR1—allergic rhinitis	3.45e-05	0.000875	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL5—allergic rhinitis	3.42e-05	0.000867	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCL11—allergic rhinitis	3.33e-05	0.000845	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL5—allergic rhinitis	3.21e-05	0.000815	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TAC1—allergic rhinitis	2.8e-05	0.000711	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TAC1—allergic rhinitis	2.79e-05	0.000707	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL5—allergic rhinitis	2.6e-05	0.000661	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL5—allergic rhinitis	2.59e-05	0.000657	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—SMAD3—allergic rhinitis	2.48e-05	0.000628	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SMAD3—allergic rhinitis	2.47e-05	0.000627	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SMAD3—allergic rhinitis	2.46e-05	0.000623	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TAC1—allergic rhinitis	2.42e-05	0.000614	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SMAD3—allergic rhinitis	2.41e-05	0.00061	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SMAD3—allergic rhinitis	2.26e-05	0.000573	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL5—allergic rhinitis	2.25e-05	0.000571	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—NFKB1—allergic rhinitis	1.95e-05	0.000495	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—NFKB1—allergic rhinitis	1.84e-05	0.000467	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SMAD3—allergic rhinitis	1.83e-05	0.000465	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SMAD3—allergic rhinitis	1.82e-05	0.000463	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TGFB1—allergic rhinitis	1.63e-05	0.000413	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SMAD3—allergic rhinitis	1.58e-05	0.000402	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TGFB1—allergic rhinitis	1.53e-05	0.000389	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—NFKB1—allergic rhinitis	1.26e-05	0.000319	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—NFKB1—allergic rhinitis	1.26e-05	0.000319	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NFKB1—allergic rhinitis	1.25e-05	0.000317	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NFKB1—allergic rhinitis	1.22e-05	0.00031	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NFKB1—allergic rhinitis	1.15e-05	0.000291	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TGFB1—allergic rhinitis	1.05e-05	0.000266	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TGFB1—allergic rhinitis	1.05e-05	0.000266	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TGFB1—allergic rhinitis	1.04e-05	0.000264	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TGFB1—allergic rhinitis	1.02e-05	0.000258	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TGFB1—allergic rhinitis	9.57e-06	0.000243	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NFKB1—allergic rhinitis	9.31e-06	0.000236	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NFKB1—allergic rhinitis	9.26e-06	0.000235	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NFKB1—allergic rhinitis	8.05e-06	0.000204	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TGFB1—allergic rhinitis	7.76e-06	0.000197	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TGFB1—allergic rhinitis	7.72e-06	0.000196	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TGFB1—allergic rhinitis	6.7e-06	0.00017	CbGpPWpGaD
